Benjamin T. Suratt

• 
  www.uptodate.com/home/clinicians/toc.do?full_url_key=tr - [Cached Version]
  Last Visited: 5/16/2009  

  Benjamin T Suratt, MD Associate Professor of Medicine and Cell and Molecular Biology University of Vermont College of Medicine

• 
  www.emphysema.net/NLNov2003/November2003.htm - [Cached Version]
  Published on: 2/13/2003    Last Visited: 11/24/2003  

  "Many of the body's tissues once thought to be only locally regenerative may, in fact, be actively replaced by circulating stem cells after hematopoietic or blood-forming stem cell transplantation," says lead author Benjamin Suratt, M.D., assistant professor of medicine and Vermont Lung Center researcher at the University of Vermont College of Medicine."This finding is of note not only for its novelty as a regenerative mechanism of the lung, but also for its vast therapeutic implications for any number of lung diseases."
  
  According to Suratt, the study's findings indicate that circulating stem cells are going into organ tissue and repairing damage, which could have a huge impact on the treatment of such devastating lung diseases as emphysema or cystic fibrosis.
  
  Supported by funding from the National Institutes of Health and a National Center for Research Resources Centers for Biomedical Research Excellence grant, Suratt and his colleagues are currently looking further into what types of cells have the capacity to differentiate and generate a different type of cell, and whether these cells might be used to treat cystic fibrosis.
  
  .....Univ.Of Vermont

• 
  ADVANCE for Managers of Respiratory Care | Editorial - [Cached Version]
  Published on: 2/9/2004    Last Visited: 2/9/2004  

  Benjamin T. Suratt, MD, of the division of pulmonary sciences and critical care medicine, University of Vermont Health Sciences Research Facility, Burlington, along with seven associates, found significant rates of epithelial (2.5 percent to 8 percent) and endothelial (37.5 percent to 42.3 percent) chimerism in lung tissue samples from two of three patients who had undergone either lung biopsy or autopsy.
  
  "Many of the body's tissues once thought to be only locally regenerative may, in fact, be actively replaced by circulating stem cells after hematopoietic stem cell transplantation," Dr. Suratt said.
  
  He noted that localization of donor-derived cells or chimerism recently had been shown to occur in the cells of mice after either hematopoietic stem cell transplantation or infusion of cultured marrow.
  
  Dr. Suratt said that his team's results suggest that significant chimerism of the human lung may follow hematopoietic stem cell transplantation and that adult human stem cells potentially could play a therapeutic role in treatment of the damaged lung.

• 
  Apologetics Press - Presidential Elections, Superman,... - [Cached Version]
  Published on: 4/1/2003    Last Visited: 7/24/2006  

  Lead researcher: Benjamin Suratt, University of Vermont College of Medicine

• 
  Education Bulletin: Professional Resources - National... - [Cached Version]
  Last Visited: 3/2/2009  

  Obesity and ALI/ARDS: How Can One Inflammatory Disease Ameliorate Another? - Benjamin T. Suratt, MD, Associate Professor of Medicine and Cell & Molecular Biology, University of Vermont College of Medicine, Burlington, VT

• 
  Lung, Resuscitation and Respiration Peer Review... - [Cached Version]
  Published on: 6/25/2005    Last Visited: 1/6/2007  

  Benjamin T. Suratt, M.D.Assistant ProfessorUniversity of Vermont, Burlington

• 
  Press Release - [Cached Version]
  Published on: 8/1/2003    Last Visited: 10/25/2006  

  Benjamin T. Suratt, M.D., of the Division of Pulmonary Sciences and Critical Care Medicine, University of Vermont Health Sciences Research Facility, Burlington, along with seven associates, in a report in the American Journal of Respiratory and Critical Care Medicine, found significant rates of epithelial (2.5 to 8 percent) and endothelial (37.5 to 42.3 percent) chimerism in lung tissue samples from two of three patients who had undergone either lung biopsy or autopsy.
  
  "Many of the body's tissues once thought to be only locally regenerative may, in fact, be actively replaced by circulating stem cells after hematopoietic stem cell transplantation," said Dr. Suratt.
  
  He noted that localization of donor-derived cells or chimerism had recently been shown to occur in the cells of mice after either hematopoietic stem cell transplantation or infusion of cultured marrow.
  
  Dr. Suratt said that his team's results suggest that significant chimerism of the human lung may follow hematopoietic stem cell transplantation and that adult human stem cells could potentially play a therapeutic role in treatment of the damaged lung.
  
  According to the authors, donor-derived epithelial and endothelial cells were predominately found in the alveoli, although donor-derived epithelial cells were occasionally found in the bronchial lining. (The bronchioles are the smaller airways with dozens of bubble-shaped, air-filled cavities at their end called alveoli.)
  
  The tissue specimens were obtained from patients at time periods ranging from 50 to 463 days after transplantation.
  
  "Although the small sample size of this study limits definitive conclusions," said Dr. Suratt, "the lack of chimerism in the second patient is of interest.

• 
  ScienceDaily News Release: Stem Cells Shown To... - [Cached Version]
  Published on: 9/1/2003    Last Visited: 9/3/2003  

  "Many of the body's tissues once thought to be only locally regenerative may, in fact, be actively replaced by circulating stem cells after hematopoietic or blood-forming stem cell transplantation," says lead author Benjamin Suratt, M.D., assistant professor of medicine and Vermont Lung Center researcher at the University of Vermont College of Medicine."This finding is of note not only for its novelty as a regenerative mechanism of the lung, but also for its vast therapeutic implications for any number of lung diseases."
  
  According to Suratt, the study's findings indicate that circulating stem cells are going into organ tissue and repairing damage, which could have a huge impact on the treatment of such devastating lung diseases as emphysema or cystic fibrosis.
  
  Supported by funding from the National Institutes of Health and a National Center for Research Resources Centers for Biomedical Research Excellence grant, Suratt and his colleagues are currently looking further into what types of cells have the capacity to differentiate and generate a different type of cell, and whether these cells might be used to treat cystic fibrosis.

• 
  Staff Directory | Medicine | Fletcher Allen Health Care - [Cached Version]
  Published on: 7/3/2009    Last Visited: 7/3/2009  

  Benjamin T. Suratt, MD Pulmonologist, Fletcher Allen Health Care Assistant Professor, University of Vermont College of Medicine

• 
  Staff Directory | Pulmonary Disease and Critical Care... - [Cached Version]
  Published on: 7/3/2009    Last Visited: 7/3/2009  

  Benjamin T. Suratt, MD
  
  Pulmonologist, Fletcher Allen Health Care Assistant Professor, University of Vermont College of Medicine

Page:  1 2